NATICK, Mass., Feb. 22, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2012 RBC Capital Markets’ Global Healthcare Conference on February 29 in New York.
Hank Kucheman, Chief Executive Officer, and Jeff Capello, Executive Vice President and Chief Financial Officer, will participate in a 25-minute question and answer session regarding the Company beginning at approximately 9:00 a.m. ET.
A live webcast of the question and answer session will be available to interested parties via Boston Scientific’s website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
This webcast is being hosted by RBC. The replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.
CONTACT: Eric Olson
336-293-4393 (office)
Media Relations
Boston Scientific Corporation
eric.olson@bsci.com
Lorie Fiber
310-854-8256 (office)
Media Relations
Weber Shandwick
lfiber@webershandwick.com
Sean Wirtjes
508-652-5305 (office)
Investor Relations
Boston Scientific Corporation
Investor_Relations@bsci.com
SOURCE Boston Scientific Corporation
